NEULAND LABORATORIES LTD.

NSE : NEULANDLABBSE : 524558ISIN CODE : INE794A01010Industry : Pharmaceuticals & DrugsHouse : Private
BSE6153.20-199.5 (-3.14 %)
PREV CLOSE ( ) 6352.70
OPEN PRICE ( ) 6352.70
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 419
TODAY'S LOW / HIGH ( )6153.20 6479.75
52 WK LOW / HIGH ( )1671.75 7450
NSE6322.15-37.8 (-0.59 %)
PREV CLOSE( ) 6359.95
OPEN PRICE ( ) 6400.00
BID PRICE (QTY) 6322.15 (190)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 16249
TODAY'S LOW / HIGH( ) 6234.05 6450.00
52 WK LOW / HIGH ( )1681.8 7318.3
Exchange
Period From    
Period To    
Exchange Deal Date Client Name Tran Qty (000's) Trade Price () Value (Rs.in Lakhs) Close Price ()

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.